Eiko Lifesciences Ltd. (EIKO) has announced a rights issue of 55,44,178 equity shares aggregating up to Rs. 24.94 crores. The rights issue opens for subscription on July 17, 2023 and closes on July 26, 2023.
Anyone who holds shares of Eiko Lifesciences Ltd. as of July 07, 2023 (record date) will be eligible for receiving Rights Entitlements (REs). These REs will be temporarily traded on the stock exchanges and will then be extinguished. You can either use the REs to apply for the rights shares of the company or you can sell them in the market.
You can check the announcement from the company here.
You will be eligible for receiving Rights Entitlements (REs) if you’ve bought the shares on or before July 6, 2023. The ex-date is July 7, 2023.
Rights issue details
| Issue Period | July 17, 2023 - July 26, 2023 |
|---|---|
| RE Trading Period | July 17, 2023 - July 20, 2023 |
| RE Symbol | EIKO-RE |
| Issue Price | Rs. 45 per share (Rs. 13.50 on application) |
| Ratio | 2:3 |
| EX-date | July 07, 2023 |
| Record Date | July 07, 2023 |
| Tentative Date of Allotment for rights shares | August 03, 2023 |
| Tentative Date of Credit of rights shares | August 04, 2023 |
| Tentative Date of Listing for rights shares | August 10, 2023 |
This is a partly-paid issue, meaning you only have to make part payment at the time of application.
| Amount payable per equity share | Face Value | Premium | Total |
|---|---|---|---|
| On Application | 3 | 10.5 | 13.5 |
| One or more additional calls as may be decided by the company | 7 | 24.5 | 31.5 |
| Total | 10 | 35 | 45 |
If you continue holding partly-paid shares of Eiko Lifesciences Ltd. when the company makes a call for the balance payment, you will be liable to pay the balance sum. If you have sold the partly-paid shares, the buyer will be liable to pay the sum.
How to apply for Eiko Lifesciences Rights Issue?
Once you either receive the REs from the company or purchase them from the market, you can apply for the rights shares using the below methods;
- Online via Netbanking ASBA
- Offline by submitting the Application Form to the nearest branch of SCSB (Self-Certified Syndicate Bank)
You can check the application process here.
You will need to enter your Demat account’s Beneficiary Owner ID which is a 16-digit number while applying for the rights issue.
The option to apply for rights shares through the RTAs portal is not available for this rights issue.
What will happen to my purchased holding of RE shares if I do not apply for the rights issue?
Your REs will lapse and you will lose the premium paid to acquire them. The RE will be in the form of temporary demat securities which will lapse if not renounced/exercised once the trading window is closed.
I don’t have the shares but bought REs, am I still eligible to apply for the rights issue?
In case you have bought REs but don’t have shares, you’re still eligible for the rights issue. You may apply for the rights shares either through the RTA’s portal or via net banking ASBA if your bank allows it. If you don’t take any action, and let the REs remain in your Zerodha account, they will lapse after the issue.
You can read more FAQs on Rights Issue and Rights Entitlements here.